Hsieh Shu-Yun, Yeh Jih-Kai, Huang Yu-Chang, Chen Dong-Yi, Ho Ming-Yun, Chen Chun-Chi, Hsieh I-Chang, Hsieh Ming-Jer
Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, Kwei-Shan, Taoyuan, Taiwan.
College of Medicine, Chang Gung University, Kwei-Shan, Taoyuan, Taiwan.
Sci Prog. 2024 Oct-Dec;107(4):368504241291125. doi: 10.1177/00368504241291125.
Hemodynamic monitoring via right heart catheterization (RHC) is critical for managing acute coronary syndrome (ACS) patients with heart failure or cardiogenic shock. However, the prognostic value of RHC-derived hemodynamic indices in ACS patients with left ventricular systolic dysfunction (LVSD) but without heart failure or shock remains uncertain.
A retrospective cohort study included 1151 consecutive ACS patients who underwent RHC during hospitalization from 2007 to 2016. After excluding patients with shock, pulmonary edema, and severe valvular disease, 750 ACS patients with LVSD and ejection fraction < 50% were analyzed. Major adverse cardiovascular events (MACEs), including myocardial infarction and all-cause mortality, were followed for five years. Cox regression identified predictors of MACEs, adjusting for comorbidities, treatments, and hemodynamic indices, including pulmonary arterial capacitance (PAC).
After a mean follow-up of 4.0 ± 1.7 years, 113 (15.1%) patients experienced MACEs. Multivariate analysis showed that independent predictors included prior stroke, calcified coronary lesions, and PAC. Patients in the lowest PAC tertile (≤2.89 ml/mmHg) had significantly higher risks of myocardial infarction (adjusted hazard ratio [HR]: 3.74; 95% confidence interval [CI]: 1.55-9.07; = .003), all-cause mortality (adjusted HR: 2.55; 95% CI: 1.27-5.10; = .008), and MACEs (adjusted HR: 2.35; 95% CI: 1.25-4.42; = .008) compared to those in the highest tertile (>4.43 ml/mmHg).
The study demonstrated that PAC is a notably strong hemodynamic parameter with independent long-term prognostic value in ACS patients with LVSD, who do not present with shock or heart failure. This is the first study to establish the prognostic significance of hemodynamic indices obtained from RHC in this population, extending the clinical relevance of RHC from high-risk to intermediate-risk ACS populations.
The use of RHC to assess hemodynamic indices, including PAC, during index hospitalization in this population may enhance long-term risk stratification and improve outcome prediction.
通过右心导管插入术(RHC)进行血流动力学监测对于管理患有心力衰竭或心源性休克的急性冠状动脉综合征(ACS)患者至关重要。然而,RHC得出的血流动力学指标在左心室收缩功能障碍(LVSD)但无心力衰竭或休克的ACS患者中的预后价值仍不确定。
一项回顾性队列研究纳入了2007年至2016年住院期间接受RHC的1151例连续ACS患者。在排除休克、肺水肿和严重瓣膜疾病患者后,对750例LVSD且射血分数<50%的ACS患者进行了分析。对主要不良心血管事件(MACE),包括心肌梗死和全因死亡率进行了为期五年的随访。Cox回归确定了MACE的预测因素,并对合并症、治疗方法和血流动力学指标(包括肺动脉容量(PAC))进行了校正。
平均随访4.0±1.7年后,113例(15.1%)患者发生了MACE。多变量分析显示,独立预测因素包括既往中风、钙化冠状动脉病变和PAC。PAC处于最低三分位数(≤2.89 ml/mmHg)的患者发生心肌梗死的风险显著更高(校正风险比[HR]:3.74;95%置信区间[CI]:1.55 - 9.07;P = 0.003),全因死亡率(校正HR:2.55;95% CI:1.27 - 5.10;P = 0.008),以及MACE(校正HR:2.35;95% CI:1.25 - 4.42;P = 0.008),与处于最高三分位数(>4.43 ml/mmHg)的患者相比。
该研究表明,PAC是一个显著强大的血流动力学参数,在无休克或心力衰竭的LVSD的ACS患者中具有独立的长期预后价值。这是第一项确定从RHC获得的血流动力学指标在该人群中的预后意义的研究,将RHC的临床相关性从高危ACS人群扩展到中危ACS人群。
在该人群的首次住院期间使用RHC评估包括PAC在内的血流动力学指标可能会加强长期风险分层并改善结局预测。